Hodson and Geddes' Cystic Fibrosis

Name: Hodson and Geddes' Cystic Fibrosis
Brand: Taylor & Francis
SKU: 9781032202204
Price: 447.0 NZD
Availability: InStock

0.0 (0 reviews)

Summary

This fifth edition of Hodson and Geddes' Cystic Fibrosis comprehensively explores the latest advances in cystic fibrosis treatment, including targeted CFTR protein modulators. It integrates fundamental science with clinical management across various economic settings and incorporates the impact of COVID-19, providing a thorough understanding of the biology of the CFTR gene and emerging therapies.
Read More

Format: Hardback

$447⁰⁰

AVAILABLE WITH SUPPLIER Ships from our Auckland warehouse within 4-6 weeks

Found a better price? Request a price match

Hodson and Geddes' Cystic Fibrosis

$447⁰⁰

Book Hero Magic created this recommendation. While it's new and still learning, it may not be perfect - your feedback is welcome! IS THIS YOUR NEXT READ?

Ideal for clinicians, trainees, multidisciplinary healthcare teams, scientists, and students seeking an authoritative, evidence-based reference on cystic fibrosis care and research.

Cystic Fibrosis has seen dramatic advances in treatment since the last edition, including targeted CFTR protein modulators for most CFTR gene abnormalities. This new edition is an update of the rapid clinical and scientific advances in improving prognosis, and the impact of CoVID-19, which has transformed conventional models of care.

Description

Hodson and Geddes' Cystic Fibrosis has seen dramatic advances in treatment since the last edition, including targeted cystic fibrosis transmembrane conductance regulator (CFTR) protein modulators for most CFTR gene abnormalities. This new fifth edition is an update and expansion of the rapid clinical and scientific advances in improving prognosis, and the impact of COVID-19, all of which has transformed conventional models of care.

It covers basic science, such as how detailed understanding of the biology of the CFTR gene and protein has led to novel and beneficial therapies, as well as all aspects of clinical management in high-, middle- and low-income settings, and the voices of individuals with CF from across the world. It will be a useful reference for clinicians, including all levels of trainees, across the whole multidisciplinary team, scientists and students.

Key Features

• Follows an appealing organisation of chapters, by developing fundamental knowledge of the reader before moving on to more complex or developing topics.

• Presents a comprehensive, authoritative and up-to-date text, integrating fundamental science and clinical aspects of cystic fibrosis, providing an attractive read for clinicians, trainee doctors and scientists.

• Draws on global expertise and reflects best evidence-based practice from experts conducting cutting-edge clinical and basic science research from around the world.

Book Details

INFORMATION

ISBN: 9781032202204

Publisher: Taylor & Francis Ltd

Format: Hardback

Date Published: 27 October 2023

Country: United Kingdom

Imprint: CRC Press

Edition: 5th edition

Illustration: 4 Tables, color; 81 Tables, black and white; 104 Line drawings, color; 36 Line drawings, black and white; 46 Halftones, color; 13 Halftones, black and white; 150 Illustrations, color; 49 Illustrations, black and white

Contributors:

Edited by Andrew Bush
Edited by Margarida D. Amaral
Edited by Jane C. Davies
Edited by Nicholas J. Simmonds
Edited by Jennifer L. Taylor-Cousar
Edited by Sarath C. Ranganathan

Audience: Tertiary education, Professional and scholarly

DIMENSIONS

Width: 210.0mm

Height: 280.0mm

Weight: 3980g

Pages: 746

Collections

Education & Reference Health & Wellness Non-Fiction

About the Author

Andrew Bush MD FHEA FRCP FRCPCH FERS FAPSR ATSFProfessor of Paediatrics and Paediatric Respirology, National Heart and Lung Institute, and Imperial Centre for Paediatrics and Child Health, Imperial College
Consultant Paediatric Chest Physician, Royal Brompton & Harefield NHS Foundation Trust
NIHR Senior Investigator Emeritus

Margarida D. Amaral
Professor
BioISI – Biosystems & Integrative Sciences Institute
Faculty of Sciences, University of Lisboa, Portugal

Jane C. Davies
Professor in Paediatric Respirology & Experimental Medicine.
Imperial College London
Honorary Consultant in Paediatric Respiratory Medicine
Royal Brompton Hospital, part of Guy’s & St Thomas’ NHS Foundation Trust
London
United Kingdom

Nicholas Simmonds MD(Res) FRCP
Associate Director | Consultant Respiratory Physician
Adult Cystic Fibrosis Centre, Royal Brompton Hospital

Professor of Practice (Respiratory Medicine)
National Heart and Lung Institute, Imperial College London

Adult Cystic Fibrosis Centre, Royal Brompton Hospital
Sydney Street, London
United Kingdom

Jennifer L. Taylor-Cousar, MD, MSCS, ATSF
President, Medical Staff
Medical Director, Clinical Research Services
Co-Director and CF TDC Director, Adult CF Program

Professor, Departments of Medicine and Pediatrics,
Divisions of Pulmonary, Critical Care and Sleep Medicine and Pediatric Pulmonary Medicine

Divisions of Pulmonary Sciences and Critical Care Medicine and Pediatric Pulmonology
University of Colorado Anschutz Medical Campus

Sarath Ranganathan MBChB MRCP FRCPH FRACP PhD FThorSoc ATSF
Stevenson Chair and Head, Department of Paediatrics | Academic Director of Clinical Education Strategy and Risk
University of Melbourne
Consultant, Respiratory and Sleep Medicine | Royal Children’s Hospital
Head, Respiratory Diseases Research Group | Infection and Immunity | Murdoch Children’s Research Institute